Preclinical study reveals durable antibacterial efficacy and low toxicity in novel gemini organosilicon surfactants, highlighting their potential for biocompatible hygienic formulations.
In this study, d-glucono delta-lactone was used as the raw material to sequentially conduct amidation, substitution, and quaternization reactions, through which a novel Gemini sugar-based amide organosilicon quaternary ammonium salt surfactant (2/3SiDDGMAPB) was designed and synthesized, and its molecular structures were confirmed by FT-IR and nuclear magnetic resonance. Notably, the results of physicochemical characterization and application performance investigation demonstrate that the surface tension of 2SiDDGMAPB is as low as 29.38 mN/m. Transmission electron microscopy, energy-dispersive spectroscopy, and dynamic light scattering characterizations reveal that 2SiDDGMAPB forms uniformly spherical micelles. The system exhibits robust foaming and foam-stabilizing performance across various water qualities and outstanding short-term foam stability in practical aqueous systems. Notably, both compounds display ultrahigh antibacterial activity against Staphylococcus aureus and Escherichia coli (with MIC as low as 0.001%), maintaining a 100% antibacterial rate even after 35 washing cycles. Toxicity tests in mice and skin irritation tests in rabbits confirm that 3SiDDGMAPB is practically nontoxic (LD50 > 5000 mg/kg) and nonirritating. 2/3SiDDGMAPB is a multifunctional surfactant combining rich foaming performance, long-acting bacteriostasis, and high biosafety, with excellent application potential and broad market prospects.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: